Global Health Limited
NSE: MEDANTAINE474Q01031·HealthcareMidcap 150·www.medanta.org ↗·Mcap ₹40,208 Cr·Listed 2022
₹1,495.40▼ ₹10.80  (−0.72%)
52W: ₹956 – ₹1,544 · Vol: 1.6L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q3 FY23
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23
Revenue from operations1,3041,1591,1211,0991,031931943957861809833844773703694
Other income22.236.721.819.720.522.91618.221.927.421.920.821.528.411.9
Total expenses1,1131,009986935863771770794739693682694653599594
EBITDA287244217231227225238228186179212213178163160
EBITDA margin22.0%21.0%19.4%21.0%22.0%24.1%25.2%23.9%21.6%22.2%25.5%25.2%23.0%23.2%23.0%
Finance costs26.726.721.517.113.81516.3161818.217.720.117.920.520.7
Depreciation6966.561.249.745.149.348.449.446.645.54442.940.43838.8
Profit before tax213187120200208133189181144143172171141133112
Tax5645.624.841.449.232.146.250.337.415.748.845.4393231.8
Net profit1571429515815910114313110612712412510210180.6
Net margin12.1%12.2%8.5%14.4%15.4%10.9%15.1%13.7%12.3%15.7%14.8%14.8%13.2%14.4%11.6%
EPS (₹)5.915.363.545.895.923.775.324.873.964.744.614.663.803.773.08
Net profit YoY−1.1%+39.7%−33.5%+21.1%+49.6%−20.4%+15.6%+4.5%+4.2%+26.0%+53.3%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23
Revenue from operations4,4103,6923,2752,694
Other income98.679.174.764.9
Total expenses3,7933,0742,7232,310
EBITDA919877799612
EBITDA margin20.8%23.8%24.4%22.7%
Finance costs79.165.373.977.9
Depreciation223194173150
Profit before tax715647627449
Tax161166149123
Net profit554481478326
Net margin12.6%13.0%14.6%12.1%
EPS (₹)20.7117.9217.8012.58
Net profit YoY+15.1%+0.7%+46.6%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23
Operating cash flow714624612645
Investing cash flow−1,065−721−441−342
Financing cash flow248−97.2−514346
Capital expenditure838517279236
Free cash flow (CFO − capex)−124107334409

Net profit trend

annual, ₹ crore
FY23
₹326
FY24
₹478+47%
FY25
₹481+1%
FY26
₹554+15%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated30 Jul 2026PDF on NSE XBRL
Q1 FY27Standalone30 Jul 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited14 May 2026PDF on NSE XBRL
Q4 FY26Standalone · audited14 May 2026PDF on NSE XBRL
Q3 FY26Consolidated4 Feb 2026PDF on NSE XBRL
Q3 FY26Standalone4 Feb 2026PDF on NSE XBRL
Q2 FY26Consolidated7 Nov 2025PDF on NSE XBRL
Q2 FY26Standalone7 Nov 2025PDF on NSE XBRL
Q1 FY26Consolidated7 Aug 2025PDF on NSE XBRL
Q1 FY26Standalone7 Aug 2025PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 57.8×72.7×
P/B5Y avg 8.51×10.14×
ROEFY26, on average equity15.1%
Net margin12.6%
Debt / equity0.30×
Revenue CAGR (3Y)17.9%
Profit CAGR (3Y)19.3%
EPS (TTM)₹20.56
Market cap₹40,180 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
10.14×
vs 7-point avg 8.51× (+19%)
5.83× low8.51× avg12.22× high
History points are balance-sheet dates (2023 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹5,905 Cr+24%
Net worth₹3,962 Cr+17%
Total borrowings₹1,190 Cr+263%
Cash & bank balances₹127 Cr−45%
Investments₹3 Cr−6%
Inventories₹79 Cr+18%
Trade receivables₹411 Cr+41%
Trade payables₹242 Cr+24%
Change vs the same date a year earlier.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Dec 23Sept 23
Promoter33.0033.0133.0133.0133.0133.0333.0333.0433.0433.0433.0533.06
FII9.4610.1510.5311.4011.5411.7612.4712.2012.9412.0911.3610.69
DII16.8914.7614.0012.9812.2011.9310.5111.1110.5710.2511.1510.93
of which MF16.0313.9113.1211.8310.66–––––––
Retail5.595.885.956.036.486.536.746.556.287.146.806.84
Other public34.9736.1336.4536.5236.7136.7537.2537.1037.1737.4837.6438.48
1,40,531 shareholders · NSE shareholding pattern filings.